We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$167B
| $99.2M | 0.65% |
1,315,475
+92,535
| +8% | +$7.36M |
|
27
Netflix
NFLX
$290B
| $94M | 0.61% |
3,182,430
+599,490
| +23% | +$16.3M |
|
28
Visa
V
$682B
| $93.4M | 0.61% |
780,682
+46,686
| +6% | +$5.66M |
|
29
Bank of America
BAC
$430B
| $92.1M | 0.6% |
3,070,316
+88,028
| +3% | +$2.77M |
|
30
AbbVie
ABBV
$450B
| $91M | 0.59% |
961,034
-56,042
| -6% | -$6.16M |
|
31
S&P Global
SPGI
$133B
| $90.4M | 0.59% |
473,057
-28,936
| -6% | -$5.34M |
|
32
UnitedHealth
UNH
$387B
| $88.9M | 0.58% |
415,406
+41,344
| +11% | +$9.44M |
|
33
Goldman Sachs
GS
$314B
| $88.4M | 0.58% |
351,161
+42,825
| +14% | +$11.1M |
|
34
PepsiCo
PEP
$187B
| $87.3M | 0.57% |
800,033
-16,826
| -2% | -$1.91M |
|
35
Abbott
ABT
$175B
| $85.9M | 0.56% |
1,434,033
-60,646
| -4% | -$3.65M |
|
36
Cintas
CTAS
$81.8B
| $84.3M | 0.55% |
1,975,948
-18,360
| -0.9% | -$762K |
|
37
Medtronic
MDT
$106B
| $83.9M | 0.55% |
1,045,759
-24,405
| -2% | -$2.01M |
|
38
Texas Instruments
TXN
$258B
| $83.5M | 0.54% |
803,962
+121,946
| +18% | +$13.2M |
|
39
General Dynamics
GD
$99.7B
| $82.8M | 0.54% |
375,028
+6,749
| +2% | +$1.47M |
|
40
Adobe
ADBE
$94.3B
| $82.7M | 0.54% |
382,935
+61,222
| +19% | +$12.4M |
|
41
Aflac
AFL
$63.5B
| $80.3M | 0.52% |
1,836,121
+15,763
| +0.9% | +$698K |
|
42
Broadcom
AVGO
$1.76T
| $77.8M | 0.51% |
3,302,140
+529,250
| +19% | +$13.3M |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $77.5M | 0.51% |
869,272
+76,031
| +10% | +$7.3M |
|
44
Ecolab
ECL
$76.8B
| $77.4M | 0.5% |
564,949
+8,508
| +2% | +$1.14M |
|
45
McCormick & Company Non-Voting
MKC
$13.9B
| $76.7M | 0.5% |
1,441,122
+55,152
| +4% | +$2.9M |
|
46
Archer Daniels Midland
ADM
$41.4B
| $76.7M | 0.5% |
1,767,485
+116,243
| +7% | +$4.89M |
|
47
Home Depot
HD
$338B
| $76.6M | 0.5% |
429,695
+46,190
| +12% | +$8.67M |
|
48
Consolidated Edison
ED
$41.4B
| $75.2M | 0.49% |
964,761
+116,259
| +14% | +$9.04M |
|
|
49
Roper Technologies
ROP
$36.6B
| $75M | 0.49% |
267,263
+252,950
| +1,767% | +$69.8M |
|
|
PX
50
DELISTED
Praxair Inc
PX
| $74.6M | 0.49% |
517,209
+437,635
| +550% | +$68.1M |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.